Skip to main content

Home
Specialties
Resources
CME

Search Videos and More

search

Channel Categories

Breast Cancer (18)
Cancer Screening and Survivorship (4)
Cell Therapy (21)
Clinical Trials (10)
COVID-19 (7)
Gastrointestinal Cancer (9)
Genitourinary Cancer (9)
Gynecologic Oncology (9)
Head and Neck Cancer (10)
Hematologic Oncology (30)
Immunotherapy (26)
Neuro-Oncology (7)
Pediatric Hematology/Oncology (8)
Primary Care (7)
Radiation Oncology (9)
Skin Cancer (7)
Thoracic Cancer (10)
Young Adult Malignancies (2)

Types

News (128)

Showing 13 - 24 of 128 results

Previous| 1 | 2 | 3 ...11 |Next

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer

Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024

Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024

Next Generation Armored Car T-Cell Therapy Trial Now Open

Next Generation Armored Car T-Cell Therapy Trial Now Open

Can FDG-PET/CT Inform Neoadjuvant Therapy for Patients with HER2+ Breast Cancer?

Can FDG-PET/CT Inform Neoadjuvant Therapy for Patients with HER2+ Breast Cancer?

Career Opportunity: Join Our Roswell Park Team

Career Opportunity: Join Our Roswell Park Team

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Study Reveals Worse Clinical Outcomes in Breast Cancer Patients Who Reported Higher Pain and Stress

Study Reveals Worse Clinical Outcomes in Breast Cancer Patients Who Reported Higher Pain and Stress

Showing 13 - 24 of 128 results

Previous| 1 | 2 | 3 ...11 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer